Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

EZ manufacturing edges towards recovery - PMI survey

(Sharecast News) - The eurozone's long-suffering manufacturing sector inched closer to recovery as the pace of contraction slowed in July, according to a survey published on Friday. The HCOB eurozone manufacturing purchasing managers' Index confirmed a flash reading, rising to 49.8 from 49.5 in June, its highest level since July 2021.

A mark of 50 separates growth from contraction.

"Manufacturing in the euro zone is cautiously regaining momentum. With the newly agreed trade framework between the EU and the US, uncertainty should decline, and the signs point to a continued upward trend in the coming months," said Cyrus de la Rubia, chief economist at Hamburg Commercial Bank.

"The eurozone as a whole saw factory production levels rise in July, marking five successive monthly expansions."

"The increase slowed slightly from June, however, and was the softest since March. Weighing on output was a fresh decline in new business. The deterioration in demand was small, but nevertheless the quickest in four months."

Export sales were a drag on total order volumes, latest survey data revealed, with new work received from international clients falling after stabilising in the previous month.

The US reached a framework trade deal with the European Union on Sunday, imposing a 15% import tariff on most EU goods.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.